enVVeno Medical Corporati... (NVNO)
3.17
-0.02 (-0.63%)
At close: Jan 14, 2025, 3:59 PM
2.97
-6.40%
After-hours Jan 14, 2025, 04:38 PM EST
undefined% (undefined)
| Bid | 3.1 |
| Market Cap | 55.59M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.29 |
| PE Ratio (ttm) | -2.46 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 3.75 |
| Volume | 68,325 |
| Avg. Volume (20D) | 148,396 |
| Open | 3.21 |
| Previous Close | 3.19 |
| Day's Range | 3.14 - 3.26 |
| 52-Week Range | 2.45 - 6.97 |
| Beta | undefined |
About NVNO
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blo...
Industry Medical - Devices
Sector Healthcare
IPO Date May 31, 2018
Employees 31
Stock Exchange NASDAQ
Ticker Symbol NVNO
Website https://www.envveno.com
3 months ago ·
Source
-28%
EnVVeno Medical shares are trading lower after the...
Unlock content with
Pro Subscription
3 months ago ·
Source
-1.75%
EnVVeno Medical shares are trading lower after the company announced a proposed public offering.
